Dan Li

6.5k total citations · 3 hit papers
156 papers, 4.7k citations indexed

About

Dan Li is a scholar working on Molecular Biology, Computational Theory and Mathematics and Genetics. According to data from OpenAlex, Dan Li has authored 156 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Molecular Biology, 41 papers in Computational Theory and Mathematics and 34 papers in Genetics. Recurrent topics in Dan Li's work include Computational Drug Discovery Methods (40 papers), Estrogen and related hormone effects (21 papers) and Prostate Cancer Treatment and Research (16 papers). Dan Li is often cited by papers focused on Computational Drug Discovery Methods (40 papers), Estrogen and related hormone effects (21 papers) and Prostate Cancer Treatment and Research (16 papers). Dan Li collaborates with scholars based in China, United States and Macao. Dan Li's co-authors include Tingjun Hou, Youyong Li, Huiyong Sun, Sheng Tian, Peichen Pan, Gaoqi Weng, Lei Xu, Zhe Wang, Feng Zhu and Yu Kang and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Dan Li

145 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HawkDock: a web server to predict and analyze the protein–protein complex based on computational docking and MM/GBSA

2019 420 citations Dan Li, Tingjun Hou et al. profile →
Assessing the performance of the MM/PBSA and MM/GBSA methods. 6. Capability to predict protein–protein binding free energies and re-rank binding poses generated by protein–protein docking

2016 374 citations Huiyong Sun, Peichen Pan et al. profile →
The application of in silico drug-likeness predictions in pharmaceutical research

2015 360 citations Dan Li, Lei Xu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dan Li China	36	2.7k	1.3k	577	484	382	156	4.7k
Rituraj Purohit India	52	3.1k 1.1×	1.3k 1.0×	531 0.9×	561 1.2×	275 0.7×	157	5.5k
Douglas S. Auld United States	42	4.8k 1.8×	1.1k 0.8×	663 1.1×	625 1.3×	365 1.0×	120	7.1k
Ajit Jadhav United States	50	5.1k 1.9×	1.3k 1.0×	1.0k 1.8×	929 1.9×	498 1.3×	150	8.1k
Nadine Homeyer Germany	11	3.3k 1.2×	1.1k 0.8×	501 0.9×	671 1.4×	225 0.6×	18	4.9k
Min Shen United States	42	3.8k 1.4×	1.5k 1.1×	879 1.5×	806 1.7×	228 0.6×	162	7.2k
Léonardo Scapozza Switzerland	43	3.6k 1.3×	523 0.4×	874 1.5×	821 1.7×	424 1.1×	187	7.4k
Susan L. McGovern United States	31	2.3k 0.8×	1.1k 0.9×	777 1.3×	607 1.3×	215 0.6×	127	5.5k
Huiyong Sun China	40	5.1k 1.9×	2.8k 2.1×	875 1.5×	1.0k 2.1×	299 0.8×	108	7.7k
Bruno O. Villoutreix France	49	3.9k 1.4×	2.3k 1.8×	616 1.1×	907 1.9×	503 1.3×	221	8.5k
Bill R. Miller United States	11	2.3k 0.9×	739 0.6×	345 0.6×	535 1.1×	221 0.6×	23	3.7k

Countries citing papers authored by Dan Li

Since Specialization

Citations

This map shows the geographic impact of Dan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Li more than expected).

Fields of papers citing papers by Dan Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Li. The network helps show where Dan Li may publish in the future.

Co-authorship network of co-authors of Dan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Li. A scholar is included among the top collaborators of Dan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Li. Dan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xie, Yanling, Qi-Zhi Su, Qin‐Bao Lin, et al.. (2025). Integration of UV-vis spectroscopy and machine learning for identification of recycled polyethylene terephthalate. Food Packaging and Shelf Life. 48. 101463–101463. 2 indexed citations

Liu, Cheng, Mingjun Jing, Dan Li, et al.. (2025). Versatile defect-laden boronizing hard carbon for superior sodium-ion battery efficacy. Chemical Engineering Journal. 520. 166436–166436.

Yang, Yan, Guanxiang Liang, Zhixuan Chen, et al.. (2025). Atractylenolide-Ⅲ binds non-structural protein-1 to suppress influenza A by modulating macrophage polarization and alternative polyadenylation. Phytomedicine. 141. 156704–156704. 1 indexed citations

Li, Lianjie, et al.. (2025). Palladium-Catalyzed Diastereoselective Imidoylative Arylation/Carbamoylation of Conjugated 1,3-Enynes. Organic Letters. 27(49). 13571–13578.

Wang, Ying, Xinyue Wang, Xin Chai, et al.. (2025). Discovery of N-(1,2,4-Thiadiazol-5-yl)benzo[b]oxepine-4-carboxamide Derivatives as Novel Antiresistance Androgen Receptor Antagonists. Journal of Medicinal Chemistry. 68(3). 3445–3459.

Chen, Kepeng, Jike Wang, Dan Li, et al.. (2025). Effective generation of heavy-atom-free triplet photosensitizers containing multiple intersystem crossing mechanisms based on deep learning. Chemical Science. 16(32). 14698–14709. 1 indexed citations

Li, Dan, et al.. (2025). Discovery of novel tetrahydroquinoline derivatives as potent, selective, and orally Available AR antagonists. European Journal of Medicinal Chemistry. 291. 117566–117566.

Li, Dan, et al.. (2025). Clinical significance of lipid pathway-targeted therapy in breast cancer. Frontiers in Pharmacology. 15. 1514811–1514811. 1 indexed citations

Zhang, Meng, et al.. (2025). ACAA2 lactylation and expression mediate mitochondrial dysfunction in phenylephrine-induced cardiomyocyte hypertrophy. Biochemical and Biophysical Research Communications. 781. 152518–152518.

10.

Yuan, Ying, Ning Zhu, Xuefeng Fang, et al.. (2024). Updated survival results of BBCAPX-II: Sintilimab combined with bevacizumab and CapeOx as first-line treatment in patients with RAS-mutant, microsatellite stable, unresectable metastatic colorectal cancer.. Journal of Clinical Oncology. 42(16_suppl). 3563–3563. 1 indexed citations

11.

Wang, Huating, Xuwen Wang, Haiyang Zhong, et al.. (2024). Discovery of 5-Nitro-N-(3-(trifluoromethyl)phenyl) Pyridin-2-amine as a Novel Pure Androgen Receptor Antagonist against Antiandrogen Resistance. Journal of Medicinal Chemistry. 67(22). 20514–20530. 1 indexed citations

12.

Yu, Yanzhen, et al.. (2024). Identification of Oral Bioavailable Coumarin Derivatives as Potential AR Antagonists Targeting Prostate Cancer. Journal of Medicinal Chemistry. 67(21). 19395–19416. 4 indexed citations

13.

Li, Shuai, Jike Wang, Odin Zhang, et al.. (2024). ClickGen: Directed exploration of synthesizable chemical space via modular reactions and reinforcement learning. Nature Communications. 15(1). 10127–10127. 10 indexed citations

14.

Ma, Ning, Bei Pan, Long Ge, et al.. (2023). Efficacy and safety of Tanreqing injection for cough caused by acute trachea-bronchitis disease: A systematic review and meta-analysis of randomized controlled trials. Journal of Ethnopharmacology. 321. 117429–117429. 3 indexed citations

15.

Chai, Xin, Xueping Hu, Xinyue Wang, et al.. (2023). Computationally guided discovery of novel non-steroidal AR-GR dual antagonists demonstrating potency against antiandrogen resistance. Acta Pharmacologica Sinica. 44(7). 1500–1518. 8 indexed citations

16.

Fu, Weitao, Hao Yang, Zhou Gong, et al.. (2023). Small-Molecule Inhibition of Androgen Receptor Dimerization as a Strategy against Prostate Cancer. ACS Central Science. 9(4). 675–684. 12 indexed citations

17.

Hu, Xueping, Jinping Pang, Changwei Chen, et al.. (2022). Discovery of novel non-steroidal selective glucocorticoid receptor modulators by structure- and IGN-based virtual screening, structural optimization, and biological evaluation. European Journal of Medicinal Chemistry. 237. 114382–114382. 20 indexed citations

18.

Hu, Xueping, Xin Chai, Qing Ye, et al.. (2021). Opportunities for overcoming tuberculosis: Emerging targets and their inhibitors. Drug Discovery Today. 27(1). 326–336. 16 indexed citations

19.

Li, Dan, et al.. (2020). Association between bilirubin levels and diabetic retinopathy in type 2 diabetes mellitus. Zhonghua neifenmi daixie zazhi. 36(3). 227–234. 1 indexed citations

20.

Zhou, Wenfang, Mojie Duan, Weitao Fu, et al.. (2018). Discovery of Novel Androgen Receptor Ligands by Structure-Based Virtual Screening and Bioassays. Genomics Proteomics & Bioinformatics. 16(6). 416–427. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact